New asthma drug candidate passes early safety check in healthy volunteers
NCT ID NCT05991661
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called XKH001 in 24 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo by injection. The goal was to check for side effects and measure drug levels in the blood, not to treat asthma. This is an early step before testing the drug in people with asthma.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Hospital of Jilin University Phase I Clinical Research Center
Changchun, Jilin, 130000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking severe asthma over time unlock better treatments?
- Can pressurized breathing boost mucus clearance in lung disease?
- Can a simple breathing test unlock the secrets of chronic cough?
- Can a Breath-Activated inhaler match the standard for asthma control?
- Can a School-Home program tame childhood asthma?
- Could everyday supplements shield your lungs?